Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지
DOI QR코드

DOI QR Code

Vitamin D Deficiency and Related Factors in Patients at a Hospice

일개 호스피스 병동에서 비타민 D 결핍 현황 및 관련인자

  • Moon, Kyoung Hwan (Department of Family Medicine, Gachon University Gil Medical Center) ;
  • Ahn, Hee Kyung (Division of Oncology, Department of Internal Medicine, Gachon University Gil Medical Center) ;
  • Ahn, Hong Yup (Department of Statistics, Dongguk University) ;
  • Choi, Sun Young (Department of Family Medicine, Korea University Guro Hospital) ;
  • Hwang, In Cheol (Department of Family Medicine, Gachon University Gil Medical Center) ;
  • Choi, Youn Seon (Department of Family Medicine, Korea University Guro Hospital) ;
  • Yeom, Chang Hwan (Ucell Clinic)
  • 문경환 (가천대학교 길병원 가정의학과) ;
  • 안희경 (가천대학교 길병원 종양내과) ;
  • 안홍엽 (동국대학교 통계학과) ;
  • 최선영 (고려대학교 구로병원 가정의학과) ;
  • 황인철 (가천대학교 길병원 가정의학과) ;
  • 최윤선 (고려대학교 구로병원 가정의학과) ;
  • 염창환 (유셀크리닉)
  • Received : 2013.11.07
  • Accepted : 2014.01.23
  • Published : 2014.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Although vitamin D deficiency is more commonly found in cancer patient than in non-cancer patients, there have been little data regarding the prevalence of vitamin D deficiency in cancer patients at the very end of life. We examined vitamin D deficiency in terminally ill cancer patients and related factors. Methods: This study was based on a retrospective chart review of 133 patients in a hospice ward. We collected data regarding age, sex, serum 25-hydroxyvitamin D level, cancer type, physical performance, current medications and various laboratory findings. We investigated factors related to serum vitamin D levels after multivariate adjustment for potential confounders. Serum 25-hydroxyvitamin D<20 ng/mL was considered deficient and <10 ng/mL severely deficient. Results: Ninety-five percent of the patients were serum vitamin D deficient. Severe vitamin D deficiency was more common in male patients, non-lung cancer patients, $H_2$ blocker users and non-anticonvulsant users. Elevated levels of serum alanine aminotransferase (ALT) were also associated with low serum vitamin D levels. Multiple regression analysis showed that severe vitamin D deficiency was associated with male gender (aOR 3.82, 95% CI: 1.50~9.72, P=0.005), $H_2$ blocker users (aOR 3.94, 95% CI: 1.61~9.65, P=0.003) and elevated serum ALT levels (aOR 4.52, 95% CI: 1.35~15.19, P=0.015). Conclusion: Vitamin D deficiency was highly prevalent among terminally ill cancer patients. Severe vitamin D deficiency was more common in male patients, $H_2$ blocker users, and patients with elevated ALT levels.

목적: 암환자에서는 비타민 D 결핍이 흔하지만, 생애 말기암환자에서 비타민 D 결핍 현황에 대한 자료는 드물다. 저자는 말기암환자를 대상으로 비타민 D 결핍 현황 및 그와 관련된 인자를 파악하고자 하였다. 방법: 일개 호스피스 병동에 입원하였던 말기암환자 133명을 대상으로 후향적 의무기록 관찰을 토대로 진행되었다. 환자의 나이, 성별, 혈중 비타민 D 수치, 암 종류, 신체기능, 약물, 그리고 혈액검사에 대한 자료를 수집하였다. 잠재적인 혼란변수를 보정한 후, 다변량 분석을 통해 혈청 비타민 D 결핍과 연관된 유의한 변수를 확인하였다. 혈청 비타민 D 수치 20 ng/mL 미만을 결핍, 10 ng/mL 미만을 중증 결핍으로 간주하였다. 결과: 대상자의 95%는 혈청 비타민 D 결핍증 상태였다. 남성, 비폐암 환자, $H_2$ 차단제 사용자, 항경련제 미사용자에서 중증 비타민 D 결핍이 더 흔하였다. 혈중 alanine aminotransferase (ALT) 상승 또한 낮은 비타민 D 수치와 관련이 있었다. 다변량 분석에서 중증 비타민 D 결핍이 있을 가능성은, 남성이 여성에 비해 3.82배(95% CI: 1.50~9.72, P=0.005), $H_2$ 차단제를 사용한 환자가 그렇지 않은 환자에 비해 3.94배(95% CI: 1.61~9.65, P=0.003), ALT상승이 있는 환자는 그렇지 않은 환자에 비해 4.52배(95% CI: 1.35~15.19, P=0.015)였다. 결론: 말기암환자에서 비타민 D 결핍 상태는 매우 흔했다. 남성, $H_2$ 차단제의 사용, 그리고 ALT의 상승이 중증 비타민 D 결핍과 관련이 있었다.

Keywords

References

  1. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S-6S.
  2. Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002;112:659-62. https://doi.org/10.1016/S0002-9343(02)01091-4
  3. Marwaha RK, Tandon N, Reddy DR, Aggarwal R, Singh R, Sawhney RC, et al. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J Clin Nutr 2005;82:477-82.
  4. Choi HS, Oh HJ, Choi H, Choi WH, Kim JG, Kim KM, et al. Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 2011;96:643-51. https://doi.org/10.1210/jc.2010-2133
  5. Klesges RC, Harmon-Clayton K, Ward KD, Kaufman EM, Haddock CK, Talcott GW, et al. Predictors of milk consumption in a population of 17- to 35-year-old military personnel. J Am Diet Assoc 1999;99:821-6; quiz 827-8. https://doi.org/10.1016/S0002-8223(99)00195-9
  6. Chen TC, Chimeh F, Lu Z, Mathieu J, Person KS, Zhang A, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 2007;460:213-7. https://doi.org/10.1016/j.abb.2006.12.017
  7. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet 1989;2:1104-5.
  8. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004;80: 752-8.
  9. Visser M, Deeg DJ, Lips P; Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88:5766-72. https://doi.org/10.1210/jc.2003-030604
  10. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343-51. https://doi.org/10.1359/jbmr.2003.18.2.343
  11. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 2009;20:315-22. https://doi.org/10.1007/s00198-008-0662-7
  12. Houston DK, Cesari M, Ferrucci L, Cherubini A, Maggio D, Bartali B, et al. Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007;62:440-6. https://doi.org/10.1093/gerona/62.4.440
  13. Dev R, Del Fabbro E, Schwartz GG, Hui D, Palla SL, Gutierrez N, et al. Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia. Oncologist 2011;16:1637-41. https://doi.org/10.1634/theoncologist.2011-0151
  14. Churilla TM, Lesko SL, Brereton HD, Klem M, Donnelly PE, Peters CA. Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case-control study. BMJ Open 2011;1:e000397.
  15. Irwin ML, Crumley D, McTiernan A, Bernstein L, Baumgartner R, Gilliland FD, et al. Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 2003;97:1746-57. https://doi.org/10.1002/cncr.11227
  16. Kailajarvi ME, Salminen EK, Paija OM, Virtanent AM, Leino AE, Irjala KA. Serum bone markers in breast cancer patients during 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy. Anticancer Res 2004;24(2C):1271-4.
  17. Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, Sunga AY. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis 2009;24:219-24. https://doi.org/10.1007/s00384-008-0593-y
  18. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777-83. https://doi.org/10.1056/NEJM199803193381201
  19. Porojnicu A, Robsahm TE, Berg JP, Moan J. Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol 2007;103:675-8. https://doi.org/10.1016/j.jsbmb.2006.12.031
  20. Zhou W, Suk R, Liu G, Park S, Neuberg DS, Wain JC, et al. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2005;14:2303-9. https://doi.org/10.1158/1055-9965.EPI-05-0335
  21. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009;27:3757-63. https://doi.org/10.1200/JCO.2008.20.0725
  22. Kim HJ, Lee YM, Ko BS, Lee JW, Yu JH, Son BH, et al. Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann Surg Oncol 2011;18:1830-6. https://doi.org/10.1245/s10434-010-1465-6
  23. To T. Vitamin D deficiency in an Australian inpatient hospice population. J Pain Symptom Manage 2011;41:e1-2. https://doi.org/10.1016/j.jpainsymman.2010.04.014
  24. Van Mechelen W, Aertgeerts B, De Ceulaer K, Thoonsen B, Vermandere M, Warmenhoven F, et al. Defining the palliative care patient: a systematic review. Palliat Med 2013;27:197-208. https://doi.org/10.1177/0269216311435268
  25. McCusker J. The terminal period of cancer: definition and descriptive epidemiology. J Chronic Dis 1984;37:377-85. https://doi.org/10.1016/0021-9681(84)90104-8
  26. Anisimov VN. Biology of aging and cancer. Cancer Control 2007;14:23-31. https://doi.org/10.1177/107327480701400104
  27. Xie L, Wu K, Xu N, Chen D, Chen J, Lu S. Hypertension is associated with a high risk of cancer. J Hum Hypertens 1999;13:295-301. https://doi.org/10.1038/sj.jhh.1000805
  28. Gallagher EJ, LeRoith D. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Ann N Y Acad Sci 2011;1243:54-68. https://doi.org/10.1111/j.1749-6632.2011.06285.x
  29. Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002;20:494-502. https://doi.org/10.1200/JCO.20.2.494
  30. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71:31-8. https://doi.org/10.1038/sj.ki.5002009
  31. Ponchon G, Kennan AL, DeLuca HF. “Activation” of vitamin D by the liver. J Clin Invest 1969;48:2032-7. https://doi.org/10.1172/JCI106168
  32. Han YP, Kong M, Zheng S, Ren Y, Zhu L, Shi H, et al. Vitamin D in liver diseases: from mechanisms to clinical trials. J Gastroenterol Hepatol 2013;28 Suppl 1:49-55. https://doi.org/10.1111/jgh.12016
  33. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007;56:2143-9. https://doi.org/10.1002/art.22722
  34. Haderslev KV, Jeppesen PB, Sorensen HA, Mortensen PB, Staun M. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut 2003;52:653-8. https://doi.org/10.1136/gut.52.5.653
  35. Robien K, Oppeneer SJ, Kelly JA, Hamilton-Reeves JM. Drug-vitamin D interactions: a systematic review of the literature. Nutr Clin Pract 2013;28:194-208. https://doi.org/10.1177/0884533612467824
  36. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005;62:265-81. https://doi.org/10.1111/j.1365-2265.2005.02226.x
  37. Stone CA, Kenny RA, Healy M, Walsh JB, Lawlor PG. Vitamin D depletion: of clinical significance in advanced cancer? Support Care Cancer 2011;19:865-7. https://doi.org/10.1007/s00520-011-1117-9
  38. Ginter JK, Krithika S, Gozdzik A, Hanwell H, Whiting S, Parra EJ. Vitamin D status of older adults of diverse ancestry living in the greater Toronto area. BMC Geriatr 2013;13:66-75. https://doi.org/10.1186/1471-2318-13-66
  39. Aquila S, Guido C, Perrotta I, Tripepi S, Nastro A, Ando S. Human sperm anatomy: ultrastructural localization of 1alpha,25-dihydroxyvitamin D receptor and its possible role in the human male gamete. J Anat 2008;213:555-64. https://doi.org/10.1111/j.1469-7580.2008.00975.x
  40. Andersson AM, Carlsen E, Petersen JH, Skakkebaek NE. Variation in levels of serum inhibin B, testosterone, estradiol, luteinizing hormone, follicle-stimulating hormone, and sex hormonebinding globulin in monthly samples from healthy men during a 17-month period: possible effects of seasons. J Clin Endocrinol Metab 2003;88:932-7. https://doi.org/10.1210/jc.2002-020838
  41. Bengoa JM, Bolt MJ, Rosenberg IH. Hepatic vitamin D 25-hydroxylase inhibition by cimetidine and isoniazid. J Lab Clin Med 1984;104:546-52.
  42. Odes HS, Fraser GM, Krugliak P, Lamprecht SA, Shany S. Effect of cimetidine on hepatic vitamin D metabolism in humans. Digestion 1990;46:61-4. https://doi.org/10.1159/000200333
  43. Richards DA. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine. J Clin Gastroenterol 1983;5 Suppl 1:81-90.
  44. Henry HL. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 2011;25:531-41. https://doi.org/10.1016/j.beem.2011.05.003
  45. Lee MH, Kim YM, Kim SG. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis. Int J Clin Pharmacol Ther 2012;50:778-86. https://doi.org/10.5414/CP201746
  46. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004;45:1330-7. https://doi.org/10.1111/j.0013-9580.2004.18804.x
  47. Flicker L, Mead K, Macinnis RJ, Scherer S, Stein MS, Thomasx J, et al. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003;51:1533-8. https://doi.org/10.1046/j.1532-5415.2003.51510.x
  48. Zhu K, Austin N, Devine A, Bruce D, Prince RL. A randomized controlled trial of the effects of vitamin D on muscle strength and mobility in older women with vitamin D insufficiency. J Am Geriatr Soc 2010;58:2063-8. https://doi.org/10.1111/j.1532-5415.2010.03142.x
  49. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010;303:1815-22. https://doi.org/10.1001/jama.2010.594
  50. Llach F, Velasquez Forero F. Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects. Am J Kidney Dis 2001;38(5 Suppl 5):S20-33.